HRT Financial’s YieldMax MRNA Option Income Strategy ETF MRNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,351
Closed -$152K 4387
2025
Q4
$152K Buy
10,351
+3,548
+52% +$56.8K ﹤0.01% 2701
2025
Q3
$120K Buy
6,803
+867
+15% +$18K ﹤0.01% 2497
2025
Q2
$139K Sell
5,936
-11
-0.2% -$271 ﹤0.01% 2146
2025
Q1
$164K Buy
+5,947
New +$228K ﹤0.01% 2068

Other funds holding MRNY

HRT Financial's MRNY Position: Q1 2026 in Review

HRT Financial sold out of YieldMax MRNA Option Income Strategy ETF (MRNY) in Q1 2026, closing a stake of 10,351 shares — an estimated $152K sold.

HRT Financial first reported a position in MRNY in Q1 2025 and held it in 4 quarters. The position peaked at $164K in Q1 2025. 11 funds tracked by Wall St. Rank hold MRNY as of Q1 2026.

  • HRT Financial reported no remaining YieldMax MRNA Option Income Strategy ETF position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 10,351 YieldMax MRNA Option Income Strategy ETF shares in Q1 2026, an estimated $152K.
  • HRT Financial first reported a position in YieldMax MRNA Option Income Strategy ETF in Q1 2025 and held it in 4 quarters.
  • HRT Financial's YieldMax MRNA Option Income Strategy ETF position peaked at $164K in Q1 2025.
  • 11 funds tracked by Wall St. Rank held YieldMax MRNA Option Income Strategy ETF as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.